Top Markets
Coin of the day
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Rang in aandelen #32246
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Aandeelprijs
$0.8013
Laatst gesynchroniseerd: 2026-08-05
Marktkapitalisatie
$10.62M
Verandering (1 dag)
0.97%
Verandering (1 jaar)
-37.88%
Land
US
Handel Hoth Therapeutics, Inc. (HOTH)

Categorie

Dividendrendementgeschiedenis voor Hoth Therapeutics, Inc. (HOTH)
Het dividendrendement (TTM) van Hoth Therapeutics, Inc. (aandelsymbool: HOTH) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Hoth Therapeutics, Inc. (HOTH) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten